DZIF researcher Oliver Cornely has been elected as a Fellow of the American Academy of Microbiology (AAM) in honour of his achievements in the field of life-threatening infections in immunocompromised
A patient who had contracted the dangerous MERScoronavirus in Abu Dhabi gave rise to public concern in Osnabrück this weekend. Many people fear a spread of the pathogen, which causes severe pneumonia
PanACEA, the Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics, presented the results of its most recent phase IIb study. The most exciting finding from the study is that high
In the journal The Lancet, DZIF researchers from the Research Center Borstel and their colleagues from England and South Africa make the case for optimising tuberculosis drug development. They
From chemistry to biology to medicine—during the course of his career, Mark Brönstrup repeatedly crossed the boundaries between these disciplines. So it comes as no surprise that today he is head of
An international group of scientists unraveled for the first time the global spread of multidrug resistant (MDR) Mycobacterium tuberculosis (MTB) strains. The study shows that efficient tuberculosis
An international team of researchers has discovered an antibiotic compound which is effective against a broad spectrum of pathogens. First tests have shown that it does not generate resistance. A
The DZIF Transplant Cohort, which was officially founded as an association in February 2014, has completed its preparations. The association can now begin with recruiting first patients and collecting
Researchers from the German Center for Infection Research (DZIF) have confirmed the spread of a “multidrug-resistant plasmid” in a hospital. This plasmid is a mobile genetic element which can transfer
